Literature DB >> 12875646

Combined aortic valve replacement and coronary artery bypass grafting with in situ arterial grafts for porcelain aorta.

Kentaro Tamura1, Fumikazu Nomura, Shogo Mukai, Masao Yoshitatsu, Jun Sakao, Katsuhiko Ihara.   

Abstract

Patients with porcelain aorta carry a high risk of cerebral as well as systemic embolism during cardiac surgery. Here we describe a case of severe aortic stenosis and coronary artery disease combined with the circumferentially calcified aorta. The patient was a 77-year-old man who successfully received four coronary artery bypass grafts with in situ arterial grafts without clamping the aorta and aortic valve replacement. Aortic valve replacement and two distal coronary artery anastomoses to the left circumflex artery and obtuse marginal branch were performed under cardiac arrest during hypothermic perfusion with endoaortic balloon occlusion, followed by partial endarterectomy and closure of the aorta buttressed with bovine pericardium under deep hypothermic circulatory arrest. While rewarming, the other two distal coronary anastomoses to the left anterior descending artery and diagonal branch were done on the beating heart in order to minimize cardiac arrest time. On-pump beating heart coronary artery bypass grafting (CABG) can be useful especially for combined complex cardiac surgery.

Entities:  

Mesh:

Year:  2003        PMID: 12875646

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  2 in total

1.  Porcelain aorta: multislice computed tomography for imaging of aortic arch calcification and modified coronary artery bypass graft.

Authors:  Christoph Langer; Dieter Horstkotte; Hans-Joachim Trappe; Georg Kleikamp; Thomas Butz
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

2.  Extraanatomical coronary artery bypass grafting in patients with severely atherosclerotic (Porcelain) aorta.

Authors:  Gokce Sirin; Kamil Sarkislali; Murat Konakci; Ergun Demirsoy
Journal:  J Cardiothorac Surg       Date:  2013-04-15       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.